Marshall Wace North America’s Imperva, Inc. IMPV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-423,937
Closed -$19.7M 1751
2018
Q3
$19.7M Sell
423,937
-136,450
-24% -$6.6M 0.14% 140
2018
Q2
$27M Sell
560,387
-227,251
-29% -$10.9M 0.15% 157
2018
Q1
$34.1M Buy
787,638
+539,056
+217% +$24.2M 0.17% 142
2017
Q4
$9.87M Buy
248,582
+206,705
+494% +$8.61M 0.05% 387
2017
Q3
$1.8M Buy
+41,877
New +$1.91M 0.01% 822

Other funds holding IMPV

Marshall Wace North America's IMPV Position: Q4 2018 in Review

Marshall Wace North America sold out of Imperva, Inc. (IMPV) in Q4 2018, closing a stake of 423,937 shares — an estimated $19.7M sold.

Marshall Wace North America first reported a position in IMPV in Q3 2017 and held it in 5 quarters. The position peaked at $34.1M in Q1 2018. 162 funds tracked by Wall St. Rank hold IMPV as of Q4 2018.

  • Marshall Wace North America reported no remaining Imperva, Inc. position as of Q4 2018 after selling out during the quarter.
  • Marshall Wace North America sold 423,937 Imperva, Inc. shares in Q4 2018, an estimated $19.7M.
  • Marshall Wace North America first reported a position in Imperva, Inc. in Q3 2017 and held it in 5 quarters.
  • Marshall Wace North America's Imperva, Inc. position peaked at $34.1M in Q1 2018.
  • 162 funds tracked by Wall St. Rank held Imperva, Inc. as of Q4 2018.

Based on Marshall Wace North America's 13F filing for Q4 2018, filed 14 Feb 2019.